Characterization of extracellular vesicles from patients with severe aortic stenosis undergoing transcatheter aortic valve implantation and assessment of their coagulation potential

13 April 2024 (00:00 - 00:00)

Organised by:

Abstract

Sign in to view the resources

About the speaker

Mrs Ebba-Louise Skogseid

Uppsala University, Uppsala (Sweden)

3 More presentations in this session

Presentation thumbnail

Long-term impact of postnatal nutritional programming on cardiac sensitivity to ischemia-reperfusion injury in vivo and on glucose metabolism

Ms E. Rigal (Dijon, FR)

Presentation thumbnail

Increased perivascular fibrosis and pro-fibrotic cellular transition in intramyocardial blood vessels in patients with myocardial infarction

Ms Z. Jiang (Amsterdam, NL)

Presentation thumbnail

Fast but not furious: neonatal cardiac fibroblasts as promoters of regeneration after myocardial infarction

Ms R. Gomes (Porto, PT)

Access the full session

Session thumbnail

Ischemia reperfusion and response to injury

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

13 April 2024 00:00 CET

You may be interested in

Congress Presentation

Isolation and quantification of circulating extracellular vesicles in myocardial homeostasis, strain and ischemia states

Congress Presentation

Human calcified aortic valves release procoagulant microparticles inducing endothelial dysfunction and thrombogenicity: Role of the AT1R/NADPH oxidases/SGLT2 pro-oxidant pathway

Congress Presentation

Aortic valve disease augments vesicular microRNA-145-5p to regulate the calcification of valvular interstitial cells via cellular crosstalk

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources